Aharon Schwartz - 18 Mar 2026 Form 3 Insider Report for BioLineRx Ltd. (BLRX)

Reporting relationship
Director
Issuer ticker
BLRX
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
30 Mar 2026, 17:59:19 UTC
Prior SEC filing
04 Sep 2025
Next SEC filing
09 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aharon Schwartz

Key filing fact

Aharon Schwartz filed Form 3 for BioLineRx Ltd. (BLRX) on 30 Mar 2026.

Key facts

  • This page summarizes Aharon Schwartz's Form 3 filing for BioLineRx Ltd. (BLRX).
  • 0 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 30 Mar 2026, 17:59.

Change

  • Previous filing in this sequence was filed on 04 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001625184 Primary reporting owner

Schwartz Aharon

Relationship
Director
Address
BIOLINERX LTD., 2 HAMA'AYAN STREET, MODII'N, ISRAEL
Signature
/s/ Aharon Schwartz
Signature date
30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLRX holding

Ordinary Shares, 0.1 NIS per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,705,000
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
49,800
Exercise price
$0.8370
Footnotes
F1, F2, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
19,800
Exercise price
$0.9200
Footnotes
F1, F3, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
19,800
Exercise price
$0.8940
Footnotes
F1, F4, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
199,800
Exercise price
$0.3560
Footnotes
F1, F5, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
79,800
Exercise price
$0.3690
Footnotes
F1, F6, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
79,800
Exercise price
$0.3880
Footnotes
F1, F7, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,080,000
Exercise price
$0.0850
Footnotes
F1, F8, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
360,000
Exercise price
$0.0810
Footnotes
F1, F9, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
360,000
Exercise price
$0.0850
Footnotes
F1, F10, F12
BLRX holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,055,000
Exercise price
$0.0520
Footnotes
F1, F11, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Options granted under the 2003 Amended and Restated Share Incentive Plan.

Footnote F2

The grant date of this grant is July 5, 2016. This option grant is fully vested as of this date.

Footnote F3

The grant date of this grant is July 5, 2017. This option grant is fully vested as of this date.

Footnote F4

The grant date of this grant is July 5, 2018. This option grant is fully vested as of this date.

Footnote F5

The grant date of this grant is July 2, 2019. This option grant is fully vested as of this date.

Footnote F6

The grant date of this grant is July 2, 2020. This option grant is fully vested as of this date.

Footnote F7

The grant date of this grant is July 2, 2021. This option grant is fully vested as of this date.

Footnote F8

The grant date of this grant is July 3, 2022. This option grant is fully vested as of this date.

Footnote F9

The grant date of this grant is July 3, 2023. This option grant is fully vested as of this date.

Footnote F10

The grant date of this grant is July 3, 2024. This option grant is fully vested as of this date.

Footnote F11

The grant date of this grant is October 1, 2024. As of this date, 856,200 of the options were vested as of the date of appointment. The remaining 1,198,800 options will vest in 7 equal quarterly installments, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Footnote F12

To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the 2003 Amended and Restated Share Incentive Plan must be registered in the name of a trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .